SCHEMBL21243941

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL21243935	0.86	KRAS (0.61)	KRASRPS6KB1PAK1ROCK2ROCK1
	SCHEMBL21243869	0.85	KRAS (0.62)	KRAS
	SCHEMBL29191268	0.76	EPHX2 (0.38)	KRASRPS6KB1EPHX2
	SCHEMBL30834529	0.76	EPHX2 (0.38)	KRASRPS6KB1EPHX2
	SCHEMBL21243933	0.73	KRAS (0.56)	KRASRPS6KB1TRPV1CDK2FLT3
	SCHEMBL21243874	0.72	KRAS (0.79)	KRAS
	SCHEMBL21243920	0.72	KRAS (0.79)	KRAS
	SCHEMBL21243889	0.72	KRAS (0.79)	KRAS
	SCHEMBL24854578	0.71	EPHX2 (0.34)	RPS6KB1EPHX2TRPV1NCF1
	SCHEMBL21259505	0.71	HRH4 (0.42)	—

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.